drugset / Trial / NCT00454870
Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine in an 8-week treatment study if MEM 3454 is a safe and effective treatment for patients with mild to moderate Alzheimer's disease.
Timeline
- Start
- 2007-02
- Primary completion
- 2007-10
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MEM 3454 | Unknown | 5 mg | — |
| Subject | MEM 3454 | Unknown | 15 mg | — |
| Subject | MEM 3454 | Unknown | 50 mg | — |